EYEPOINT PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Feb 2025)
What this means for you
Registered since 01 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87821925
- Registration number
- 5875068
- Mark type
- Stylized text
- Filed
- 06 Mar 2018
- Published for opposition
- 07 Aug 2018
- Registered
- 01 Oct 2019
- Attorney of record
- Kimberly Jarman, Esq.
Goods and services
- Class 005 — Pharmaceuticals: House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease
- Class 010 — Medical apparatus: House mark for sustained drug delivery systems for pharmaceuticals
Owner
- EYEPOINT US, INC., WATERTOWN, MA, US
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- pSivida US, Inc., Watertown, MA, US
Prosecution history
- 11 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 01 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED